Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY28.69 CNY
Change Today -1.04 / -3.50%
Volume 24.2M
As of 3:05 AM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

jiangsu kanion pharmaceuti-a (600557) Snapshot

Open
CNY28.67
Previous Close
CNY29.73
Day High
CNY28.91
Day Low
CNY28.15
52 Week High
04/22/15 - CNY30.59
52 Week Low
04/28/14 - CNY21.75
Market Cap
14.7B
Average Volume 10 Days
18.6M
EPS TTM
CNY0.66
Shares Outstanding
513.7M
EX-Date
06/27/14
P/E TM
43.8x
Dividend
CNY0.10
Dividend Yield
0.35%
Current Stock Chart for JIANGSU KANION PHARMACEUTI-A (600557)

Related News

No related news articles were found.

jiangsu kanion pharmaceuti-a (600557) Related Businessweek News

No Related Businessweek News Found

jiangsu kanion pharmaceuti-a (600557) Details

Jiangsu Kanion Pharmaceutical Co. Ltd. is engaged in the contract manufacture of herb medicines primarily in China. The company’s services include formula design, workmanship design, lab inspection, trial production, purchase of materials for production and package, batch production, packing and labeling, bulk sale, and new product consultation and development services. It offers herb powders and extracts, diet supplements, herb medicines, and other products in various forms, including tablets, granules, hard capsules, soft gel capsules, oral liquids, TCM injections, and lyophilized powder injections. The company exports its products to Europe and North America. Jiangsu Kanion Pharmaceutical Co. Ltd. was founded in 1975 and is headquartered in Lianyungang, China.

Founded in 1975

jiangsu kanion pharmaceuti-a (600557) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jiangsu kanion pharmaceuti-a (600557) Key Developments

Jiangsu Kanion Pharmaceutical Co. Ltd. Reports Earnings Results for 2014

Jiangsu Kanion Pharmaceutical Co. Ltd. reported earnings results for 2014. For the period, basic earnings per share was CNY 0.64. Weighted average return on net assets was 15.87%.

Jiangsu Kanion Pharmaceutical Co. Ltd. to Report Fiscal Year 2014 Results on Apr 24, 2015

Jiangsu Kanion Pharmaceutical Co. Ltd. announced that they will report fiscal year 2014 results on Apr 24, 2015

Jiangsu Kanion Pharmaceutical Co. Ltd., Board Meeting, Feb 09, 2015

Jiangsu Kanion Pharmaceutical Co. Ltd., Board Meeting, Feb 09, 2015. Agenda: To discuss and approve the proposal of replacing self-raised funds invested in advance in investment projects financed by raised funds with raised funds.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600557:CH CNY28.69 CNY -1.04

600557 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600557.
View Industry Companies
 

Industry Analysis

600557

Industry Average

Valuation 600557 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JIANGSU KANION PHARMACEUTI-A, please visit www.kanion.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.